首页> 外文OA文献 >Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials

【2h】

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials

机译：胰高血糖素的肽-1受体激动剂用于治疗非酒精性脂肪肝疾病和非酒精性脱脂性肝炎：随机对照试验的更新荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Alessandro Mantovani; Graziana Petracca; Giorgia Beatrice; Alessandro Csermely; Amedeo Lonardo; Giovanni Targher;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet [J] . Miaomiao Jin, Xiaohong Niu, Yan Liu, Open medicine . 2020,第1期

机译：胰高血糖素肽-1受体激动剂对大鼠非酒精性脂肪肝病的脂肪磷水平的影响
2. Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials [J] . Nreu Besmir, Dicembrini Ilaria, Tinti Federico, Nutrition, metabolism, and cardiovascular diseases: NMCD . 2020,第7期

机译：用胰高血糖素肽-1受体激动剂治疗的患者的主要心血管事件，心力衰竭和心房颤动：随机对照试验的更新荟萃分析
3. The efficacy of glucagon-like peptide 1 receptor agonists in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials [J] . Simin Fan, Xiaoyan Shi, Jia Yao, Revista Espaola de Enfermedades Digestivas . 2020,第8期

机译：胰高血糖素肽1受体激动剂在非酒精性脂肪肝病患者中的疗效：随机对照试验的系统审查和荟萃分析
4. A Deep Learning Approach for Classifying Nonalcoholic Steatohepatitis Patients from Nonalcoholic Fatty Liver Disease Patients Using Electronic Medical Records [C] . Pradyumna Byappanahalli Suresha, Yunlong Wang, Cao Xiao, Health Intelligence Workshop;Association for the Advancement of Artificial Intelligence Annual Conference . 2020

机译：使用电子医疗记录对非酒精性脂肪肝病患者的非酒精性脂肪性肝炎患者的深入学习方法
5. LRH-1 Signaling and Control of Liver Intermediary Metabolism: Impact on Nonalcoholic Fatty Liver Disease [D] . Silva, Vera Mónica Lemos da. 2018

机译：LRH-1肝脏中间代谢的信号和控制：对非酒精性脂肪肝病的影响
6. Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials [O] . Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, 2021

机译：胰高血糖素的肽-1受体激动剂用于治疗非酒精性脂肪肝疾病和非酒精性脱脂性肝炎：随机对照试验的更新荟萃分析
7. One Year’s Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial [O] . Louise Vedtofte, Emilie Bahne, Signe Foghsgaard, 2020

机译：一年的胰高血糖素肽1受体激动剂林雷德蛋白质的治疗降低了非酒精性脂肪肝疾病的肝脏脂肪含量，并在随机安慰剂对照试验中降低了非酒精性脂肪肝疾病和现有妊娠期糖尿病的孕妇

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials

著录项

引文网络

相似文献

相关主题

期刊订阅